Physician profile
Isida Byku
NPI 1457650871
$77,698.55
in general payments reported to CMS, 2019-2025
11 companies · $67K in 2025
The $67K reported for 2025 was more than what 99% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,138 · 2020: $54.38 · 2021: $881 · 2022: $885 · 2023: $2,270 · 2024: $4,595 · 2025: $67K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $63K · Travel and Lodging: $7,791 · Food and Beverage: $3,362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $62,587.50 |
| Travel and Lodging | $7,790.63 |
| Food and Beverage | $3,362.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $70,005.28 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Evoque, Sapien 3 Ultra Resilia |
| Shockwave Medical, INC | $2,156.13 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic Vascular, INC. | $2,030.65 | 2019-2020 | |
| Abbott Laboratories | $1,224.33 | 2019-2024 | Mitraclip |
| Boston Scientific Corporation | $950.30 | 2021-2025 | Avvigo Guidance System, Stingray, General - Atherectomy |
| Angiodynamics, INC. | $734.55 | 2025 | Alphavac, Angiovac |
| Medtronic, INC. | $329.43 | 2021-2024 | Corevalve Evolut R |
| W. L. Gore & Associates, INC. | $88.47 | 2021-2024 | Gore Cardioform Septal Occluder |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $81.53 | 2022 | |
| Abiomed | $51.03 | 2022 | |
| Amgen INC. | $46.85 | 2023 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Isida Byku listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.